TRACON Pharmaceuticals

IPO

TRACON Pharmaceuticals, Inc.

Public · San Diego, United States · Founded 2004 · $41.0M raised

Employees
11–50
Founded
2004
Business Model
B2B
Total Funding
$41.0M
Last Round
$14.0M Series AApr 2011
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

TRACON Pharmaceuticals, Inc. (OTC: TCON) is a San Diego-based clinical-stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for oncology and ophthalmology, including cancer and age-related macular degeneration. Incorporated in Delaware in October 2004 under the name Lexington Pharmaceuticals, the company rebranded as TRACON and went public. TRACON's drug development strategy centers on leveraging its cost-efficient clinical development model to in-license and advance promising compounds through clinical trials. The company has collaborated with major pharmaceutical and biotechnology partners to co-develop and commercialize oncology assets.

Summary

TRACON Pharmaceuticals is a Biotech company based in San Diego, United States, founded in 2004. It has raised $41.0M in total across 2 rounds, most recently a $14.0M Series A round in Apr 2011. Investors include Nextech Invest, Rally Ventures and Arcus Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPO2015 (est.)

Sign up to see all 3 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TRACON Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/tracon-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/tracon-pharmaceuticals" alt="TRACON Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>